Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA food advisory committee working group to discuss Ma Huang adverse events.

This article was originally published in The Tan Sheet

Executive Summary

MA HUANG SAFETY TO BE REVIEWED BY FDA FOOD ADVISORY COMMITTEE WORKING GROUP in a two-day meeting scheduled for Oct. 11-12. The agency publicly indicated its intention to review dietary supplements containing natural ephedra in a Sept. 21 Federal Register notice announcing the availability of adverse event reports related to "food products" containing ephedrine alkaloids. FDA said it has received over 300 ephedrine-related reports.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts